CoChat

Melanoma Resistance: A Bright Future for Academicians and a Challenge for Patient Advocates

Open access
Slominski, Andrzej T., Carlson, J. Andrew · 2014 · Mayo Clinic Proceedings
Cited by 127

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

In this issue of Mayo Clinic Proceedings , 2 complementary papers review recent advances in the contemporary therapy of melanoma 1 and provide a speculative synthesis 2 on the similarities between the mechanism protecting the fetus from an immune response by the mother and the evasion of host responses by metastatic melanoma. The first of these articles, by Shah and Dronca, 1 predicts a bright future for academicians and clinicians who will be responsible for evaluating and clinically applying multiple new strategies proposed to treat this devastating disease. That treatment will likely involve a flurry of new molecules and treatment modalities that are currently being developed. 1 These novel patient- and tumor-specific therapies are expected to target the hallmark features of cancer that promote cancer formation and progression (Table). 3 The second article, by Enninga et al, 2 discusses multiple mechanisms used by the placenta to protect itself and the fetus from the mother’s immune attack. Mechanisms similar to these can potentially be used by metastatic melanoma to evade the host response and immunotherapy. 2 The multiplicity of potential mechanisms listed 2 will secure the academic future for years to come as we attempt to resolve new methods for targeting immune modulation as a treatment for patients with melanoma. Unfortunately, the immediate future is not so bright for these patients currently available or developing treatment strategies are able to prolong life for only a few months before the disease relapses, modest improvements overall survival typically occur during periods in which the therapies, which are very expensive, produce toxic adverse effects. occurs melanoma multiple hinder older therapies. resistance not limited microenvironment, generate

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mayocp.2014.02.009

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 127

Metadata

Authors
Slominski, A. T., & Carlson, J. A.
Venue
Mayo Clinic Proceedings
Publisher
Elsevier BV
Published
2014-04
Volume
89
Issue
4
Pages
429-433
ISSN
0025-6196 (ISSN-L)
OpenAlex
W1992331783
Cited by
127
References
8
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Melanoma Resistance: A Bright Future for Academicians and a Challenge for Patient Advocates. https://app.cochat.ai/papers/10.1016/j.mayocp.2014.02.009
The paper
Slominski, A. T., & Carlson, J. A. (2014). Melanoma Resistance: A Bright Future for Academicians and a Challenge for Patient Advocates. Mayo Clinic Proceedings. https://doi.org/10.1016/j.mayocp.2014.02.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.